Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Kappos

Showing results (171-180 of 225) with videos related to

Pageof 23
Sort By:
Neurology|February 1, 1995
Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up studyM Filippi, D W Paty, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up studyS Mesaros, Ma Rocca, Mp Sormani, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Neurology|May 25, 2012
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trialM S Freedman, J S Wolinsky, B Wamil, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosisH Butzkueven, J Chapman, E Cristiano, et al.
Neurology|November 9, 2005
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trialsF Barkhof, U Held, J H Simon, et al.
Neurology|January 14, 2011
Stress hormones predict cerebrovascular re-events after transient ischemic attacksM Katan, N Nigro, F Fluri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2010
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksS A Morrow, P W O'Connor, C H Polman, et al.
Pageof 23

Showing results (171-180 of 225) with videos related to

Sort By:
Pageof 23
Neurology|February 1, 1995
Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: a follow-up studyM Filippi, D W Paty, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 21, 2010
Bimonthly assessment of magnetization transfer magnetic resonance imaging parameters in multiple sclerosis: a 14-month, multicentre, follow-up studyS Mesaros, Ma Rocca, Mp Sormani, et al.
Neurology|August 18, 2006
Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromesL Kappos, C H Polman, M S Freedman, et al.
Neurology|May 25, 2012
Teriflunomide added to interferon-β in relapsing multiple sclerosis: a randomized phase II trialM S Freedman, J S Wolinsky, B Wamil, et al.
European Journal of Neurology|February 1, 2017
Survey of diagnostic and treatment practices for multiple sclerosis in EuropeO Fernández, M Delvecchio, G Edan, et al.
European Journal of Neurology|January 23, 2018
Survey of diagnostic and treatment practices for multiple sclerosis (MS) in Europe. Part 2: Progressive MS, paediatric MS, pregnancy and general managementO Fernández, M Delvecchio, G Edan, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosisH Butzkueven, J Chapman, E Cristiano, et al.
Neurology|November 9, 2005
Predicting gadolinium enhancement status in MS patients eligible for randomized clinical trialsF Barkhof, U Held, J H Simon, et al.
Neurology|January 14, 2011
Stress hormones predict cerebrovascular re-events after transient ischemic attacksM Katan, N Nigro, F Fluri, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 27, 2010
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeksS A Morrow, P W O'Connor, C H Polman, et al.
Pageof 23